These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 28093207)

  • 21. Zyxin is a critical regulator of the apoptotic HIPK2-p53 signaling axis.
    Crone J; Glas C; Schultheiss K; Moehlenbrink J; Krieghoff-Henning E; Hofmann TG
    Cancer Res; 2011 Mar; 71(6):2350-9. PubMed ID: 21248071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.
    Ghosh JC; Altieri DC
    Clin Cancer Res; 2005 Jun; 11(12):4580-8. PubMed ID: 15958644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of p53 in insulin-like growth factor binding protein-3 regulation in the breast cancer cell response to DNA damage.
    Marzec KA; Lin MZ; Martin JL; Baxter RC
    Oncotarget; 2015 Sep; 6(29):26583-98. PubMed ID: 26378048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histone acetyltransferase inhibitor II induces apoptosis in glioma cell lines via the p53 signaling pathway.
    Xu LX; Li ZH; Tao YF; Li RH; Fang F; Zhao H; Li G; Li YH; Wang J; Feng X; Pan J
    J Exp Clin Cancer Res; 2014 Dec; 33(1):108. PubMed ID: 25523932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ZNF185 is a p53 target gene following DNA damage.
    Smirnov A; Cappello A; Lena AM; Anemona L; Mauriello A; Di Daniele N; Annicchiarico-Petruzzelli M; Melino G; Candi E
    Aging (Albany NY); 2018 Nov; 10(11):3308-3326. PubMed ID: 30446632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.
    Moh MC; Zhang T; Lee LH; Shen S
    Carcinogenesis; 2008 Dec; 29(12):2298-305. PubMed ID: 18845560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of LIMA1 Indicates Poor Prognosis and Promotes Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma.
    Ma W; Liao Y; Gao Z; Zhu W; Liu J; She W
    Clin Med Insights Oncol; 2022; 16():11795549221109493. PubMed ID: 35837368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lima1 mediates the pluripotency control of membrane dynamics and cellular metabolism.
    Duethorn B; Groll F; Rieger B; Drexler HCA; Brinkmann H; Kremer L; Stehling M; Borowski MT; Mildner K; Zeuschner D; Zernicka-Goetz M; Stemmler MP; Busch KB; Vaquerizas JM; Bedzhov I
    Nat Commun; 2022 Feb; 13(1):610. PubMed ID: 35105859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NKD1 correlates with a poor prognosis and inhibits cell proliferation by inducing p53 expression in hepatocellular carcinoma.
    Zhang S; Li J; Wang X
    Tumour Biol; 2016 Oct; 37(10):14059-14067. PubMed ID: 27507614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.
    Fortunato O; Boeri M; Moro M; Verri C; Mensah M; Conte D; Caleca L; Roz L; Pastorino U; Sozzi G
    Cell Death Dis; 2014 Dec; 5(12):e1564. PubMed ID: 25501825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
    Huang K; Tang Y; He L; Dai Y
    Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.
    Wu J; Wu G; Lv L; Ren YF; Zhang XJ; Xue YF; Li G; Lu X; Sun Z; Tang KF
    Carcinogenesis; 2012 Mar; 33(3):519-28. PubMed ID: 22198213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. H19-derived miR-675 contributes to bladder cancer cell proliferation by regulating p53 activation.
    Liu C; Chen Z; Fang J; Xu A; Zhang W; Wang Z
    Tumour Biol; 2016 Jan; 37(1):263-70. PubMed ID: 26198047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amplification of ACK1 promotes gastric tumorigenesis via ECD-dependent p53 ubiquitination degradation.
    Xu SH; Huang JZ; Chen M; Zeng M; Zou FY; Chen D; Yan GR
    Oncotarget; 2017 Feb; 8(8):12705-12716. PubMed ID: 26498357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of p53 expression and apoptosis by vault RNA2-1-5p in cervical cancer cells.
    Kong L; Hao Q; Wang Y; Zhou P; Zou B; Zhang YX
    Oncotarget; 2015 Sep; 6(29):28371-88. PubMed ID: 26318295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
    Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
    Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRKL oncogene is downregulated by p53 through miR-200s.
    Tamura M; Sasaki Y; Kobashi K; Takeda K; Nakagaki T; Idogawa M; Tokino T
    Cancer Sci; 2015 Aug; 106(8):1033-40. PubMed ID: 26079153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of p53-inducible gene 3 is significant for glioblastoma progression and predicts poor patient prognosis.
    Quan J; Li Y; Jin M; Chen D; Yin X; Jin M
    Tumour Biol; 2017 Mar; 39(3):1010428317694572. PubMed ID: 28351326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LMO4 inhibits p53-mediated proliferative inhibition of breast cancer cells through interacting p53.
    Zhou X; Sang M; Liu W; Gao W; Xing E; Lü W; Xu Y; Fan X; Jing S; Shan B
    Life Sci; 2012 Sep; 91(9-10):358-63. PubMed ID: 22906635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.